Testis cancer
Author(s) -
Omar Khan,
Andrew Protheroe
Publication year - 2007
Publication title -
postgraduate medical journal
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.568
H-Index - 99
eISSN - 1469-0756
pISSN - 0032-5473
DOI - 10.1136/pgmj.2007.057992
Subject(s) - medicine , seminoma , testicular cancer , radiation therapy , cancer , etiology , chemotherapy , oncology , gynecology , pathology , surgery
Testis cancer is an increasing problem, especially in northern European male populations. However, survival has improved dramatically over one generation. Environmental factors may have a role in the aetiology with high oestrogen concentrations implicated. Testis cancer is subdivided between seminoma and non-seminoma. At presentation, a testicular lump is the most common finding and radical inguinal orchidectomy is recommended for most. Further multidisciplinary management is determined by histological subtype and stage and involves chemotherapy, radiotherapy and surgery, with many patients only undergoing surveillance. There is increasing emphasis on reducing toxicity of treatments in long term survivors. Treatment refractory testis cancer remains a significant challenge.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom